Study of Varying Injection Schedules of TDENV-PIV Vaccine With AS03B Adjuvant and Placebo in Healthy US Adults

NCT02421367 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

140

Enrollment

FED

Sponsor class

Conditions

Dengue

Interventions

BIOLOGICAL: TDENV-PIV with AS03B adjuvant. Placebo: 0.9% Sodium Chloride Solution.

Sponsor

U.S. Army Medical Research and Development Command

Collaborators

[object Object]
[object Object]